Peijun Tu
@rebecca2046.bsky.social
Senior Editor @ Nature Communications (cancer therapy). Views of my own.
Q&A: Translational Cancer Nanomedicine
We gather insights from two experts with distinct perspectives on cancer nanomedicine development 👇
www.nature.com/articles/s41...
We gather insights from two experts with distinct perspectives on cancer nanomedicine development 👇
www.nature.com/articles/s41...
September 18, 2025 at 5:42 AM
Q&A: Translational Cancer Nanomedicine
We gather insights from two experts with distinct perspectives on cancer nanomedicine development 👇
www.nature.com/articles/s41...
We gather insights from two experts with distinct perspectives on cancer nanomedicine development 👇
www.nature.com/articles/s41...
28th Chinese Society of Clinical Oncology (CSCO) Annual Conference in Jinan, China, more information 👇
reg2025.csco.org.cn/35?lang=en
reg2025.csco.org.cn/35?lang=en
September 13, 2025 at 3:05 AM
28th Chinese Society of Clinical Oncology (CSCO) Annual Conference in Jinan, China, more information 👇
reg2025.csco.org.cn/35?lang=en
reg2025.csco.org.cn/35?lang=en